C

Castle Biosciences

D
CSTL
USD
0.26
(0.8575%)
Market Closed
10,610.00
Volume
-0.48
EPS
-
Div Yield
-254.833330
P/E
848,190,120.80
Market Cap
Today
0.8575%
1 Week
-0.326%
1 Month
9.371%
6 Months
58.036%
12 Months
82.132%
Year To Date
41.705%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
T
TNET
0.83
(0.8501%)
USD
A
APPS
-0.01
(-0.3448%)
USD
F
FSLY
0.1
(1.4205%)
USD
N
NET
4.79
(6.1339%)
USD
Z
ZS
4.11
(2.4393%)
USD
DDOG
DDOG
2.37
(2.0946%)
USD
O
OKTA
1.14
(1.5428%)
USD
PANW
PANW
3.73
(1.131%)
USD
S
SPLK
(%)
USD
CRWD
CRWD
10.24
(3.8345%)
USD

Title:
Castle Biosciences

Sector:
Healthcare
Industry:
Diagnostics & Research
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.
Do you need help or have a question?
Contact Us